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ABSTRACT  We have examined the uptake and distribution of 1251-1abeled human high density 
lipoprotein, apolipoprotein E-free (hHDL3), 1251-rat high density lipoprotein (HDL), and human 
HDL (hHDL) reconstituted with  [3H]cholesteryl linoleate after their in situ vascular perfusion 
to ovaries  of gonadotropin-primed  immature rats on days 6-9 post human chorionic gonad- 
otropin  (hCG)-injection.  Some  rats were treated with 4-aminopyrazolopyrimidine  to reduce 
plasma  lipoproteins  and  ovarian  cholesteryl  ester  stores.  Perfused  ovaries  were  analyzed 
biochemically  and  autoradiographically,  and  progestin  content of the  ovarian  effluent  was 
quantified.  Infusion  of  ovine  luteinizing  hormone  and  hHDL  increased  ovarian  progestin 
secretion severalfold,  indicating that the perfused  ovary was functional. After perfusion with 
HDL  reconstituted  with  [3H]cholesteryl  linoleate,  radioactive  progestin  appeared  in  the 
effluent; thus, sterol carried by exogenous HDL was converted to steroid. At 37°C, uptake of 
~251-hHDL3 was greatest after 15 min of perfusion with label. This was decreased  by 80% when 
the perfusion was carried out at 4°C and by 70-95% when excess unlabeled hHDL, but not 
human low density lipoprotein (hLDL), was included in the perfusate  with ~251-hHDL. Amino- 
pyrazolopyrimidine treatment enhanced '251-hHDL uptake twofold. After perfusion for 15 min 
with  ~251-hHDL3, radioactivity  in the ovary was  high for  3-30  min  of  HDL-free  wash,  then 
declined 75% by 30-60 min. With light and electron microscope autoradiography, 12Sl-hHOL3 
was localized to corpora lutea, both along luteal cell surfaces and over their cytoplasm. The 
plasma  membrane grains appeared to be associated with segments that lacked  bristle  coats. 
Perfusion  with  ~251-rat HDL produced a similar  pattern of labeling.  In ovaries  perfused  with 
'251-BSA, silver  grains  were  concentrated  over  macrophage-like  cells  but  were  sparse over 
luteal  cells.  We  conclude  that  the  in  situ  perfused  rat  ovary  takes  up  I~51-hHDL3 by  a 
temperature-dependent, lipoprotein-specific process, and that this lipoprotein is accumulated 
by luteal cells. 
Highly luteinized  ovaries of rats  appear to  use  exogenous 
cholesterol in the form of high density lipoproteins (HDL)  ~ 
as a primary source of sterot for the biosynthesis of steroid 
hormones (2, 23, 30, 33). HDL is taken up by steroid-secreting 
cells of the rat through a saturable process that seems to differ 
from the well characterized pathway for the  uptake of low 
~Abbreviations  used in  this paper:  APP, 4-aminopyrazolapyrimi- 
dine; HDL, high density lipoprotein; hCG, human chorionic gonad- 
otropin; hHDL, human HDL; hHDL~, apolipoprotein E-free hHDL; 
hLDL, human  LDL; KRB, Krebs-Ringer-bicarbonate buffer; LDL, 
low density lipoprotein; LH, luteinizing hormone; and TCA, trichlo- 
roacetic acid. 
density lipoproteins (LDL) (3,  7,  19). Additional  data sup- 
porting this view come from work of Kita et al. (18).  They 
have shown that antibodies to the bovine adrenal LDL recep- 
tor do not block the uptake of ~2SI-HDL by mouse adrenal 
gland in vivo, whereas they inhibit the uptake of 12~I-LDL  by 
that tissue.  Moreover, the sites involved in the uptake of HDL 
and LDL differ in several ways, including their requirements 
for divalent cations and sensitivity to proteases, and in the 
ability of heparin to displace the bound ligand (9,  10). The 
sites with which HDL associates thus appear to be distinctly 
different from those for LDL. 
However, the  identity of the  cells that bear the  putative 
HDL binding sites remains in question.  Schuler et al.  (30) 
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parenchymal cells.  On the other hand,  Kovanen et al.  (19), 
in studies of adrenal cortex, have raised the possibility that 
binding sites for HDL need not reside on adrenocortical cells; 
e.g., HDL may be taken up and processed by capillary endo- 
thelial  cells.  It is  particularly  important  to  identify  which 
specific structures and cells in the ovary take up HDL because 
this  organ  has several compartments which  make steroids, 
i.e.,  follicles,  corpora lutea,  and  interstitial cells.  Moreover, 
each contains several types of cells. 
Most of the information available on the uptake and me- 
tabolism of lipoproteins, including  HDL, by the ovary and 
other tissues has emerged from studies of  dispersed or cultured 
cells  or  from  work  on  whole  animals.  Each  of these  ap- 
proaches, however, has certain limitations. For example, when 
cells are removed from their normal environment and placed 
in  culture,  they may express phenotypes not  normally ex- 
pressed in situ. As a consequence, even though in vitro studies 
have  provided  much  valuable  information  on  lipoprotein 
metabolism, it is not yet clear whether similar processes are 
used in the intact organ. There are also a number of problems 
in studies using whole animals, where labeled lipoproteins are 
injected into the systemic circulation. They include (a) me- 
tabolism  of exogenous lipoproteins by other organs before 
they reach the tissue of interest; (b) exchange of lipoprotein 
components in  the  circulation;  and  (c)  dilution  of labeled 
lipoproteins by endogenous lipoproteins. 
Clearly,  there  is  a  strong  need  to  examine  lipoprotein 
metabolism as it occurs in the intact organ and to identify by 
morphological means those compartments and cells that take 
up HDL. To this end, we studied the distribution and metab- 
olism of ~251-1abeled human and rat HDL after administration 
of these  lipoproteins to ovaries of rats via in  situ  vascular 
perfusion. This approach offers several advantages over other 
systems previously employed. First, it permits the responses 
of ovarian cells to be studied under conditions that mimic the 
normal physiological situation.  During in situ perfusion the 
ovary remains relatively undisturbed  and,  importantly,  its 
constituent cells maintain their structural relationships with 
each other and the surrounding tissues.  Moreover, the exog- 
enous lipoproteins must cross the vascular wall to gain access 
to  ovarian  cells,  as  would  occur  in  the  normal  situation. 
Secondly, lipoproteins are delivered directly to the ovary, thus 
avoiding the complications accompanying systemic adminis- 
tration. 
Our main probe in these studies has been ~2SI-labeled hu- 
man  HDL3  (hHDL3).  Subclasses  of human  HDL  contain 
various amounts of apolipoproteins A-I, A-II, Cs, and E (12). 
Since apolipoprotein E is recognized by binding sites for LDL 
(2 1  ), we used human HDL that was essentially free of apoli- 
poprotein E to insure that we were examining the HDL and 
not the LDL pathway. 
MATERIALS  AND  METHODS 
Animals:  Highly  luteinized  ovaries were produced in  immature CD- 
strain rats 21  d  old (Charles River Breeding Laboratories, Inc., Wilmington, 
MA) by priming the rats with 50 IU of pregnant mares serum gonadotropin 
(Organon Inc., Oss, The Netherlands), followed 60 h later with 25 IU of human 
chorionic gonadotropin (hCG, Sigma Chemical Co., St. Louis, MO). Rats were 
used on days 6-9  after hCG injection,  when HDL uptake is maximal (33). 
Some gonadotropin-primed rats received  intraperitoneal  injections of 4-ami- 
nopyrazolopyrimidine (APP, Aldrich Chemical Co., Inc., Milwaukee, WI), 10 
mg/kg body wt, dissolved in sodium phosphate buffer, pH 3, for three successive 
days prior to use. This treatment lowers plasma cholesterol from 50 mg/dl to 
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<15 mg/dl within 24 h and reduces ovarian cholesteryl ester stores (31). 
Isolation  and  Labeling  of  Lipoproteins  and  Albumin: 
Human LDL (density =  1.019-1.063 g/ml) and human and rat HDL (density 
=  1,125-1.21  g/ml) were isolated from blood of normal human donors or rats 
according to Havel et al.  (14).  hHDLa prepared in this manner is essentially 
free of apolipoprotein E (10). 
The lipoproteins were labeled with ~2Sl by the iodine monochloride technique 
of Bilheimer et al. (5) to specific activities of 150-450 cpm/ng of HDL protein. 
Labeled rat lipoproteins contained somewhat higher amounts of ~2Sl in lipid 
(~ 10%) than did human lipoproteins (<2%). The percentage of radioactivity 
not precipitable by trichloroacetic acid (TCA) was always <2% for all labeled 
lipoproteins. BSA (Sigma Chemical Co.) was labeled  with ~2~I using lactoper- 
oxidase to a specific activity of 300 cpm/ng. 
Reconstitution  of  HDL  with  [3H]Cholesteryl  Linoleate: 
[ 1,2,6,7-3H]Cholesteryl  linoleate was reconstituted into hHDL apolipoproteins 
by the procedure of Hirz and Scanu (15). HDL was delipidated by the procedure 
of Scanu and Edelstein (28).  Delipidated apolipoproteins were sonicated with 
a mixture of lipids such that the apolipoproteins constituted 57%  by weight; 
egg phosphatidylcholine, 26% by weight; free cholesterol, 2% by weight; ester 
cholesterol ([3H]cholesteryl  linoleate)  11% by weight; and tripalmitin, 4% by 
weight.  The  mixture  of apotipoproteins  and  lipid  was  subjected  to  sonic 
irradiation and the sonicated material was then adjusted to a density of 1.215 
g/ml and centrifuged to isolate reconstituted HDL, which was dialyzed exten- 
sively against 0.15 M NaCI containing 0.01% EDTA, pH 7.4. 
Reconstituted HDL had a weight ratio of protein/sterol of 2:1. The specific 
activity of the [3H]cholesteryl  linoleate was 5,077-9,787 dpm/nmol. Less than 
1.6%  of the  3H was in  free  cholesterol.  Radioactivity  in  these preparations 
migrated with native HDL on cellulose acetate electrophoresis, and the recon- 
stituted  preparation  gave a  line  of identity  with  native  HDL  upon double 
immunodiffusion using a rabbit anti-human HDL antiserum. 
Analytical Methods:  Progesterone (11) and 20-a-hydroxypregn-4-en- 
3-one (24) was quantitated by specific  radioimmunoassays. Protein was deter- 
mined by the method of Lowry et al.  (20) using BSA as a  standard,  in some 
experiments, ovaries were homogenized in 2 ml of 0.9%  saline, and aliquots 
were added to an equal volume of cold 20% TCA. After standing at 4"C for 30 
rain,  the  mixture was centrifuged at  3,000  g  for  10  min and  the  resultant 
supernatant was counted.  Other aliquots of the homogenate were extracted 
with 5 vol of chloroform/methanol (2:1,  vol/vol) and the radioactivity in the 
organic phase was quantified. 
A single  mean was derived for all animals in a given treatment group and 
the means were compared among groups with one-way analysis of variance 
and subsequent Newman-Keuls' test. 
Perfusion  of  the  Ovary  and  Collection  of  the  Effluent: 
Labeled and/or unlabeled human or rat lipoproteins, ~2SI-BSA, or ovine lutein- 
izing hormone (LH) were delivered to the ovary using a  modification of the 
perfusion method of Paavola (25). No attempt was made to separate the uterine 
artery from its companion vein since manipulation of these vessels  brought 
about their constriction. Thus, the ligature securing the in-flow cannula was 
placed around both uterine vessels instead of around only the artery, as is the 
case for other animals. The ovary was then perfused, at a  flow rate of 1-1.5 
ml/min, in sequence for varying periods of time with (a) Krebs-Ringer-bicar- 
bonate buffer (KRB;  37"C,  300  mOsmol, pH 7.4,  2  mg/ml glucose, without 
lipoproteins) to wash out blood; (b) KRB containing labeled and/or unlabeled 
lipoproteins, labeled albumin, or LH; and (c) lipoprotein-free KRB to wash out 
unbound label.  The ovary was then either (a) excised,  freed of adhering tissue, 
weighed,  subjected to gamma spectrometry (counting efficiency:  70%),  and 
then  frozen  for subsequent biochemical  analyses or  fixed by immersion in 
Bouin's fluid;  or (b) perfused for an additional 45 min with cold  1% parafor- 
maldehyde-1% glutaraldehyde-0.01% trinitrocresol (16) in 0.1  M sodium cac- 
odylate buffer at pH 7.4,  excised,  counted using a gamma spectrometer, and 
processed for autoradiography as described below. 
In some studies, the effluent from the ovary was collected as follows. After 
cannulating the uterine artery, a second cannula (No. 23 gauge needle attached 
to a short length of No. 60 polyethylene tubing containing heparin) was placed 
in the ovarian vein and secured with a ligature.  The samples of ovarian effuent 
were then centrifuged as necessary to remove any blood, frozen, and  subse- 
quently subjected to steroid analysis. In these studies, 2% BSA was added to 
the KRB to facilitate  secretion of steroids. 
To study the conversion of [aH]cholesteryl  linoleate carried by reconstituted 
HDL into steroids, animals were pretreated  with APP for 3  d  prior to the 
experiment, which was performed on day 6 post-hCG injection. Ovaries were 
first perfused with KRB for 30 min and then for a  20-rain period with KRB 
containing 15 #g of reconstituted HDL/ml (9.6 x  l05 dpm/ml) with or without 
333 #g of native HDL/ml. 
The venous effluent was extracted with 6 vol of chloroform/methanol ( 12:1, vol/vol). The organic phase was dried under nitrogen and the residue subjected 
to thin-layer chromatography on Whatman K5 plates (Whatman Laboratory 
Products Inc., Clifton, N J) using hexane/ethyl acetate (7:3, vol/vol) as a solvent 
system. Areas where [3Hlprogesterone and [3H]20-a-hydroxypregn-4-en-3-one 
migrated,  identified  under UV light using authentic  "cold" standards, were 
collected into vials for liquid scintillation counting using Biofluor (New England 
Nuclear, Boston, MA). 
Autoradiography:  Immersion-fixed ovaries were processed by routine 
methods for light microscopy and embedded in paraplast or glycolmethacrylate. 
Ovaries previously fixed by perfusion were washed overnight at 4"C in 0.1  M 
sodium cacodylate  buffer; one-half was dehydrated  in  graded ethanols and 
embedded in low viscosity epoxy resin (32),  and the other was embedded in 
glycolmethacrylate. 
For light  microscope autoradiography,  sections of immersion- (5-6  ~m 
paraffin, 2-3 um glycolmethacrylate) or perfusion- (1-1.5 gm epoxy, 2-3 #m 
glycolmethacrylate) fixed tissue were placed  on acid-cleaned,  chrome alum- 
gelatin coated glass slides.  Under a Wratten No. 2 red safelight,  the slides were 
dipped in melted (43"C), undiluted Kodak NTB-3 nuclear emulsion and placed 
in  light-tight  boxes. After autoradiographic exposure in the dark at  4"C  for 
varying periods of time, the sections were developed (undiluted Kodak D-19 
developer, 2.5 min, 19"C), washed, and fixed by photographic means. Following 
washing and air-drying, they were stained with hematoxylin-eosin (paraffin) or 
methylene blue-azure II (glycolmethacrylate, epoxy) and viewed with a bright 
field  microscope. To  insure that  no sites of uptake  of '251-1ipoprotein were 
overlooked,  slides  were  processed  at  weekly  intervals  until  the  maximum 
number of silver grains was formed. 
For electron microscope autoradiography, pale-gold thin sections of epoxy- 
embedded tissue were picked up on 0.5% celloidin-coated  copper grids.  The 
sections were coated with Ilford L-4 nuclear emulsion (llford Ltd., Ilford, Essex, 
England) (diluted  1:1 with distilled  water) by the loop method of Caro and van 
Tubergen (8). After autoradiographic exposure, the sections were developed in 
freshly prepared D-19 for 2 min at  19"C, washed briefly with distilled  water, 
fixed,  and washed again. After air drying, the sections were treated with  1 N 
NaOH to remove gelatin from the emulsion, and with amyl acetate to remove 
celloidin;  this greatly improved visibility  of the tissue. They were then stained 
with uranyl acetate for 30 min and with lead citrate (26) for 5-15  min. For 
purposes of quantitation, cells to be photographed were selected in a predeter- 
mined manner to insure randomness, i.e.,  for each interval studied, the first 
30-48 cells encountered that were overlain by one or more silver grains were 
photographed. The final prints were enlarged to 16,000 x. Grains were consid- 
ered to be associated with the plasma membrane if they were within 250 nm 
of this  structure  and  to  be  intracellular  if they  were  >500  nm  from  the 
plasmalemma. 
Controls were carried out to rule out the presence of positive or negative 
chemography. The specificity  of the autoradiographic localizations was evalu- 
ated by perfusing a 350-fold excess of unlabeled hHDL or hLDL to the ovary 
simultaneously with labeled lipoprotein. 
RESULTS 
Steroid Secretion by the Perfused Ovary 
To determine whether the ovary remained functional dur- 
ing in situ perfusion, we examined its steroidogenic response 
to lipoproteins and LH. The pattern of steroid secretion was 
examined for ovaries of non-APP treated (control) and APP- 
treated rats perfused with lipoprotein-free KRB for 165 min, 
the maximum length of perfusion used in this work. APP, an 
adenine analogue, reduces lipoprotein  secretion by the liver 
and produces a marked hypercholesterolemia (1) and reduces 
stores  of ovarian  cholesteryl  esters  (31).  For  these  studies, 
effluent  from the  ovary was collected for successive  5-min 
periods and analyzed for progestin content. The total proges- 
tin  secreted  by ovaries  of non-APP treated  rats  fluctuated 
from rat to rat but was consistently high in each animal for 
the first  15-20  rain of perfusion,  after which it declined to 
fairly constant  levels (Fig.  1).  This  decline  was anticipated 
since perfused ovaries are isolated from the circulatory system 
and therefore no longer exposed to trophic factors and lipo- 
proteins normally present in plasma. A similar trend of pro- 
gestin secretion was evident in rats treated with APP, although 
the level of steroid secretion was severalfold lower than that 
for non-APP treated animals (Fig. 1). This presumably reflects 
the depletion  of endogenous sterol  substrates  as a  result  of 
APP treatment. 
The response of the perfused ovary to exogenous lipopro- 
reins was analyzed in APP-treated rats,  since it was felt that 
an  enhancement  in  sterol  synthesis  or  secretion  would  be 
more readily detected in these animals. Ovaries were infused 
with  hHDL  at  cholesterol  concentrations  of ~200  ~g/ml, 
values  which  are  roughly one-third  to  one-half of normal 
plasma cholesterol levels.  Administration of hHDL increased 
the amount of progestin in the effluent by two- to threefold 
within  5  min after perfusate containing lipoprotein reached 
the organ, as compared with controls (Fig. 2). Steroid secretion 
remained elevated for 30-35 min, and then declined to pre- 
HDL infusion levels.  In contrast to the situation for hHDL, 
where a statistically significant increment in progestin secre- 
tion  was  noted,  infusion  of hLDL to  the  ovaries  of APP- 
treated rats did not significantly elevate the level of steroids 
in  the  effluent  over the  time  periods  we  studied  (Fig.  2). 
However, the mean values in the presence of  LDL were greater 
than those for controls over the perfusion period. 
The ability of the ovary in non-APP treated rats to respond 
to ovine LH administered after varying intervals of perfusion 
with KRB was also examined. When LH was infused at 50, 
90, or 120 min after perfusion with KRB was begun, it brought 
about in each case an immediate and marked augmentation, 
from more than four- to tenfold, in steroid secretion (Fig. 3). 
As lipoproteins were not present in the perfusate, the steroids 
secreted were presumably from endogenous stores of choles- 
terol. 
To determine whether cholesterol carried by the exogenous 
hHDL was being utilized as a  substrate  for steroidogenesis, 
some  ovaries  were  infused  with  HDL  reconstituted  with 
[3H]cholesteryl linoleate,  and the  effluent was analyzed for 
radioactive steroids. As shown in Table I, the effluent from 
ovaries perfused  for 20  min  with  [3H]cholesteryl linoleate- 
reconstituted  HDL  contained  3H-labeled  progestin.  More- 
over, the amount of [3H]progestin in the outflow from the 
ovary decreased when the perfusate contained a 20-fold excess 
of unlabeled hHDL and 3H-CE-HDL. 
Uptake of 1251-Human HDL by Perfused Ovaries 
As shown in Fig. 4, the perfused ovaries accumulated 1251- 
hHDL, with  uptake  reaching a  maximum  after  15  min  of 
perfusion  with  label.  The  mean  uptake  of label  by ovaries 
perfused for  15  min with  ~25I-hHDL was 271,370 _  42,243 
cpm/ovary (mean _  SE, n =  7). 
To determine whether uptake of ~25I-hHDL by the perfused 
ovary  was  specific,  a  350-fold  excess  of either  unlabeled 
human HDL or human LDL (0.87  mg of hHDL or hLDL 
protein/ml  of perfusate)  was  administered  to the  ovary si- 
multaneously  with  ~25I-hHDL.  Specificity  of accumulation 
was then evaluated after a  15-min perfusion with label, when 
lipoprotein uptake was maximal in our studies. When excess 
unlabeled hHDL was included in the perfusate, uptake of ~25I- 
hHDL was decreased  by  70-95%  (cpm/mg ovary, wet  wt) 
(Figs. 4 and 5). In contrast, addition of an excess of unlabeled 
hLDL to the perfusate  diminished  uptake of ~25I-hHDL  by 
only 32% (Fig. 5). 
To  establish  the  effect  of temperature  on  the  uptake  of 
hHDL by the perfused ovary, we examined accumulation of 
~25I-hHDL3 at  37* and 4"C in APP-treated animals.  Uptake 
at  37"C was carried  out as described above.  Uptake  in the 
cold was accomplished by switching to perfusate maintained 
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FIGURE  1  Steroid  secretion  by  perfused 
ovaries of control  (non-APP treated) and 
APP-treated  rats.  Ovaries were  perfused 
for  165 min with  KRB  buffer and ovarian 
effluent was collected over 5-rain intervals 
from control (n =  3) and APP-treated (n = 
3) animals. Rats were treated with APP for 
the  3  d  prior  to  the  experiment, which 
was  done on  day 8  post-hCG  injection. 
Progesterone  and  20-~-hydroxypregn-4- 
en-3-one content of the effluent was de- 
termined and expressed as the sum of the 
two steroids. 
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FIGURE  2  Effect of human HDL and human LDL on steroid secre- 
tion by perfused  rat ovaries. Rats were treated with APP for three 
consecutive days before the experiment, which was done on day 
8 post-hCG injection. Ovaries were perfused for 10 min with KRB 
buffer, for 30 min with buffer containing either hHDL (n =  3; 200 
/~g HDL cholesterol/ml of perfusate) or hLDL (n =  3; 200/~g of LDL 
cholesterol/ml  of  perfusate),  and  then  with  buffer.  Ovaries  of 
control  rats  (n  =  3)  were  perfused  with  buffer  alone.  Ovarian 
effuent, collected over 5-min  intervals, was assayed for  progestin 
as described in the text. The arrow at the left indicates the initiation 
of  lipoprotein  infusion,  that  at  the  right  the  termination.  Values 
presented are means _  SE. Analysis of variance reveals that there 
are differences among the three groups at 15-35  min of perfusion 
(F =  13.3, 7.0, 12.5, 19.3, and 22.1, respectively; dr= 8). With  the 
Newman-Keuls' test,  statistical differences  were located between 
the control and HDL-treated group at 15-35 min of perfusion (P < 
0.001, except for 30  min,  P <  0.05).  Values for control and  LDL- 
treated rats were not statistically different. 
at  4°C,  and  by  surrounding  the  ovary with  ice  chips  and 
flushing it with  ice-cold saline.  Perfusion of the ovary with 
~251-hHDL at  4"C  reduced  accumulation  of the  ligand  by 
~80% compared with ovaries perfused at 37"C. At 4"C, the 
ovary took up 425 ___ 35 cpm/mg ovary (mean _+ SE, n =  3), 
whereas at 37"C it accumulated 2274 ___ 584 cpm/mg ovary 
(mean ___ SE, n --- 5). 
Finally, the possibility that the ovary was selectively accu- 
mulating degraded materials,  such as free or lipid-associated 
~251, was ruled out as follows. Ovaries from rats perfused at 
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FIGURE  3  Effect of LH on steroid secretion by perfused rat ovaries. 
After 50 (upper panel), 90 (middle panel), or 120 (lower panel) rain 
of perfusion  with  KRB  buffer,  ovine LH  (100  ng/ml  of perfusate) 
was infused into the ovaries for a period of 10 min (bar with arrows); 
this was followed by buffer alone. Ovarian effluent, collected over 
10-min intervals, was analyzed for progestin content. Rats, treated 
for 3 d with APP prior to the experiment, were used on day 7 post- 
hCG injection. Each panel represents a separate animal. 
37"C for 15 min with 1251-hHDL3 and washed for 3 min with 
KRB were homogenized and aliquots subjected to TCA pre- 
cipitation and chloroform/methanol extraction. The amount TABLE  I 
Metabolism of [1,2,6,7-3H]CholesteryI Linoleate Reconstituted into Human HDL by Perfused Rat Ovaries 
Treatment 
Radioactivity in pro- 
gesterone and 20-a- 
Radioactivity in ve-  hydroxypregn-4-en- 
Perfusion No.  Ovarian wt  nous effluent  3-one  Conversion 
Reconstituted 3H-HDL 
Reconstituted 3H-HDL 
and "cold"  HDL 
mg  dpm x  10  -6  dpm x  10  -4  % 
1  91.8  7.14  19.4  2.72 
2  75.5  3.86  17.49  4.53 
3  62.2  0.70  3.53  5.02 
4  104.1  0.55  2.69  4.62 
5  55.6  9.87  10.91  1.11 
6  101.3  7.77  8.51  1.09 
Animals were pretreated with 4-APP for 3 d prior to the experiment, which was performed on day 6 post-hCG treatment. The ovaries were 
first perfused with KRB for 30 rain and then for a 20-rain period with KRB containing 18/~g/ml (9.6 x  105 dpm) reconstituted HDL (1, 2, 5, 
and 6),  21  /~g/ml (0.95  x  10  s dpm) reconstituted  HDL  (3 and 4), or reconstituted  HDL and  333 ~g/ml of unlabeled HDL  (5 and 6).  The 
ovarian effluent was collected for analysis of radioactive products as described in the text. 
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FIGURE  4  Time course of accumulation of 1251-hHDL3 by perfused 
rat ovaries. Rats (not treated with APP) were used on day 6  post- 
hCG  injection.  Ovaries were  perfused  briefly with  KRB  buffer  to 
flush out the blood, then for 5-35  min with 1251-hHDL3 (106 cpm/ 
ml of perfusate; specific activity, 400 cpm/ng of HDL protein), after 
which they were perfused for 3 min with buffer to remove unbound 
label. Ovaries were excised and counted.  Each  point represents a 
separate animal. This experiment was repeated twice with  similar 
results. 
of radioactivity in the TCA-soluble and  organic phases was 
determined. TCA precipitated ~95%  of the radioactivity in 
these ovaries and chloroform/methanol extracted <2% of the 
label (n =  5). 
Effect of APP Treatment on Uptake of 12~I-hHDL 
by Perfused Ovaries 
In  our  initial studies,  uptake  of J2SI-hHDL3  was  high  in 
ovaries of rats that were primed with pregnant mares serum 
gonadotropin-hCG  but  that  received  no  further  treatment. 
However,  subsequent  studies indicated that  the amount  of 
uptake, although following the same pattern, was variable in 
these animals, with  some ovaries accumulating <350  cpm/ 
mg ovary. Our preliminary morphological studies suggested 
that  '2-SI-hHDL3  uptake  should  be  in  excess of 500-1,000 
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F2GURE  5  Specificity of lipoprotein uptake by perfused rat ovaries. 
Rats (not treated with APP) were used on day 6 post-hCG injection. 
After a  brief rinse with  KRB  buffer,  ovaries were  perfused  for  15 
min  with  *251-hHDL3 (106 cpm/ml  of perfusate) with  or without a 
350-fold excess (0.87 mg/ml of perfusate) of either unlabeled hHDL 
or unlabeled hLDL. They were then perfused for 3 min with buffer 
alone to remove unbound  label and  handled as described  in the 
legend to  Fig.  4.  Each  point  represents a  separate animal. Similar 
results were obtained on three separate occasions for HDL and on 
two separate occasions for LDL. 
cpm/mg tissue in order to carry out autoradiography success- 
fully within a  reasonable amount of time. We therefore ex- 
amined  uptake of ~-'~I-hHDL  in  rats  that  had  been  treated 
with APP for 3 d before use. 
We found that perfusion of I-'5I-hHDL3 to ovaries of APP- 
treated rats resulted in at least a  2-fold increase in uptake of 
label compared to rats receiving gonadotropins alone. Uptake 
of label in APP-treated animals was rarely ~<1,000  cpm/mg 
ovary and reached as high as 6,000 cpm/mg ovary. 
Pulse-Wash Studies with 1251-hHDL 
For these studies,  ovaries of rats,  either with  or without 
APP treatment, were perfused first for 15 rain with J25I-hHDL, 
then for 3-150 min with KRB lacking both label and lipopro- 
teins. While the pattern of uptake was similar in  both  non- 
APP treated and APP-treated rats, in the latter case the curve 
was shifted to the left (Figs. 6  and  7).  The amount  of label 
accumulated initially was high and more or less constant on 
a per milligram ovary basis for up to 15 rain of wash for non- 
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FIGURE  6  Pulse-wash studies in  non- 
APP  treated  rats.  Rats  were  used  on 
day  7  post-hCG  injection.  Ovaries 
were perfused briefly with KRB buffer, 
"pulsed"  for  15  min  with  12Sl-hHDL3 
(106  cpm/ml  of  perfusate)  and  then 
"washed"  for  3-150  min  with  buffer 
alone.  After  removal,  ovaries  were 
counted.  Each  point represents a sep- 
arate animal. This experiment was re- 
peated twice with similar results. There 
was no APP treatment. 
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Rats  were  treated  with  APP  for  3  d  prior  to  the 
experiment, which  was performed  on  day  7  post- 
~  hCG  injection.  The  perfusion  sequence and  proc- 
essing of ovaries was performed as described in the  --2  X 
legend to Fig. 6, except that after labeling with 1251- 
hHDL3  ovaries were  washed  for  3-120  min  with  O 
KRB buffer. Each point represents a separate animal. 
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APP treated rats and up to 30 min for APP-treated animals. 
By 30 (non-APP treated rats) or 60 (APP-treated rats) min of 
postlabel perfusion, the amount of radioactivity within the 
ovary declined by ~75%, and remained at the same level for 
the duration of the infusion period. 
Autoradiographic Localization of 1251-labeled 
Lipoproteins and Albumin 
The compartments accumulating lipoprotein were localized 
in paraffin sections of immersion-fixed tissue by light micro- 
scope autoradiography after perfusion of the ovary for 15 min 
with  J25I-hHDL3 and  a  brief buffer wash.  In this  material, 
silver grains were numerous over corpora lutea,  but sparse 
over follicles,  stroma, and ova (Fig.  8 a). When excess unla- 
beled hHDL was perfused to the ovary along with ~25I-hHDL3, 
the number of silver grains over corpora lutea was markedly 
reduced  (Fig.  8 b).  In contrast,  the  level of labeling in  this 
compartment was not appreciably altered when "cold" hLDL 
was infused to the ovary simultaneously with t25I-hHDL3 (Fig. 
8c). 
To identify the specific types of ovarian cells accumulating 
~25I-hHDL3, uptake of this  lipoprotein was  also studied  in 
plastic sections of ovaries fixed in situ by vascular perfusion. 
The quality of morphological preservation in these prepara- 
tions  was  superior  to  that  of tissue  fixed  by  immersion. 
Moreover, blood was washed  out  of the  vascular bed  and 
there  was  a  slight  shrinkage  of the  cells.  As  a  result,  the 
boundaries  of adjacent  cells  were discernible,  allowing the 
cells taking up t25I-hHDL to be recognized easily. 
After perfusing for  15  min with  '25I-hHDL3  and washing 
for 3 min to remove unbound label, it was clear that in such 
preparations most silver grains were concentrated over luteal 
cells (Fig. 9). Silver grains were associated with the cell surfaces 
and  also occurred over their cytoplasm. Silver grains were 
especially abundant along those surfaces of luteal cells that 
faced capillaries (Fig.  10a), although they were also observed 
at interfaces between adjacent luteal cells (Fig.  10b). In ~20- 
25% of the luteal cells in a given field, silver grains were near 
the nucleus (Fig.  10c). In all cases, a variable number of  grains 
was clustered in or near blood vessels. 
Silver grains  occurred  in  locations  similar to  those just 
described after being washed with lipoprotein-free buffer for 
15 (non-APP treated rats) and 30 (APP-treated rats) min (Fig. 
11 a). However, in ovaries "washed" for longer periods with 
buffer (i.e., 30-150 min for non-APP treated rats and 60-120 
rain  for APP-treated rats) the number of grains over luteal 
cells was drastically reduced (Fig.  11 b). The concentration of 
silver grains in or near blood vessels appeared unchanged as 
compared with that observed at shorter wash times. 
598  THE JOURNAL  OF  CELL  BIOLOGY  .  VOLUME  97,  1983 FIGURE  8  Light microscope autoradiographs of immersion-fixed, paraffin-embedded ovaries perfused with ~Sl-human  HDL3. 
Ovaries were perfused briefly with lipoprotein-free KRB buffer, then for 15 min with 12Sl-hHDL3 (106 cpm/ml of perfusate; specific 
activity, 400 cpm/ng of HDL protein) with or without a 350-fold excess (0.87 mg/ml of perfusate)  of unlabeled hHDL or hLDL, 
followed by a brief buffer wash to remove unbound label. (a) Silver grains (small black dots) were numerous over corpora lutea, 
but sparse over follicle and  stromal cells  in ovaries perfused with ~2Sl-hHDL3. (b)  In  contrast,  few silver grains occurred over 
corpora lutea (CL) of ovaries perfused simultaneously with  ~2Sl-hHDL~ and  excess  unlabeled hHDL.  (c)  Inclusion  of excess 
unlabeled hLDL in the perfusate with ~2Sl-hHDL3 did not markedly alter the number of silver grains over corpora lutea. CL, corpus 
luteum; ct,  connective tissue  at center of corpus luteum; st,  stroma. All,  no APP treatment; day 6  post-hCG  injection; 14-d 
autoradiographic exposure; x  600. 
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the  concentration  of grains  associated  with  luteal  cells  in 
plastic  sections  of perfusion-fixed  material  decreased  when 
excess unlabeled hHDL was added to the perfusate along with 
'25I-hHDL3 (Fig.  10, d and e). There was a similar paucity of 
silver grains over corpora lutea when t25I-hHDL3 was perfused 
to ovaries prechilled to 4"C (Fig.  10f). These comparisons of 
relative grain concentrations were matte among tissue sections 
exposed in the dark for similar amounts of time. 
Some ovaries were perfused with  ~2SI-rat HDL to rule out 
the  possibility that  heterologous  (human)  lipoprotein  might 
have a distribution  among various ovarian compartments or 
cell types different  from that  for homologous  (rat)  lipopro- 
teins. As shown in Fig.  1 l, c and d, silver grains were numer- 
FIGURE 9  Localization of hHDL3 in light microscope autoradiographs  of perfusion-fixed, glycolmethacrylate-embedded  ovary. 
After a brief perfusion with buffer,  the ovary was infused with 12SI-hHDL~  (106 cpm/ml of perfusate) for 15 min and washed for 3 
min with buffer, after which it was perfused-fixed in situ with FGC-cacodylate. The quality of morphological preservation in these 
preparations was markedly improved compared with ovaries fixed by immersion.  As a result, it was clear that silver grains were 
primarily associated with luteal cells  (arrows); few grains were observed  over cells of follicles or stroma.  Luteal cells can  be 
identified by their abundant cytoplasm and large, round nuclei which often contain prominent nucleoii. The small, dark irregularly 
shaped nuclei belong primarily to endothelial  cells. Blood cells were washed out of the vascular bed by the perfusion  (by, blood 
vessel). APP-treated; day 7 post-hCG  injection; 6-wk autoradiographic  exposure; x  1,100. 
600  THE  JOURNAL OF  CELL BIOLOGY - VOLUME 97,  1983 FIGURE 10  Light  microscopic autoradiographs of ovaries  perfused  with  12Sl-hHDL3. (a-c)  Detail of 12Sl-hHDL~  distribution in 
corpora lutea. The experiment  was done as described in the legend to Fig. 9. Silver grains were especially numerous along those 
luteal cell surfaces facing the vascular bed (a, arrows), although some were also observed at interfaces between adjacent luteal 
cells (b, arrows). Silver grains were frequently near the nucleus,  often encircling it (c, arrow).  All, x  1,800. (d-f)  Competition 
control and effect of temperature on 12Sl-hHDL3  uptake.  At 37°C, ovaries perfused with ~2Sl-hHDL3  (106 cpm/ml of perfusate) 
showed numerous silver grains which occurred over the cytoplasm and along the surfaces of luteal cells (d, arrows). In contrast, 
in autoradiographs of ovaries perfused with either T251-hHDL3  and an excess of unlabeled hHDL at 37°C (e, arrow) or ~2Sl-hHDl_ 
at 4°C (f, arrow),  few silver grains were over luteal cells. Blood vessels, by. All, x  1,200. a, b, and d-f: APP-treated; day 7 post- 
hCG  injection; perfusion-fixation; 6-wk autoradiographic exposure,  c:  No APP treatment; day 6 post-hCG  injection; perfusion- 
fixation; 7-mo autoradiographic exposure. 
601 FiGure  11  (a and b) Uptake of 12Sl-hHDL3,  pulse-wash studies. Silver grain distribution in ovaries periused for ~  5 rain with 12Sl- 
hHDL3 (106 cpm/ml oi perfusate) and washed for up to 15 (non-APP treated rats) or 30 (APP-treated rats) min was the same as 
that in ovaries washed for 3 rain (compare with Fig. 9); i.e., grains were concentrated over luteal cells (a, arrows). However, after 
longer washes the number of grains associated with luteal cells was markedly reduced (b, arrow; 120 min of wash). Blood vessels, 
by. Both, APP-treated; day 7 post-hCG  injection; 21-d autoradiographic exposure; x  1,200. (c and d) Uptake of 1251-rat HDL by 
perfused  rat ovaries. In autoradiographs of ovaries perfused for 15 min with homologous lipoprotein (~2Sl-rat HDL; 106 cpm/ml 
of perfusate; specific activity, 400 cpm/ng of HDL protein) and washed for 3 rain, silver grains were numerous along luteal cell 
suriaces and over their cytoplasm  (c, arrows). In ovaries washed ior longer periods after labeling, grains were sparse over luteal 
cells (d, arrow indicates  a silver grain over a luteal cell).  Blood vessels, by. Both, APP-treated; day 7 post-hCG  injection; 14-d 
autoradiographic  exposure, c, x  1,200; d, x  1,800. 
ous over luteal cells at 3 min of wash, whereas at 90 min of 
wash few grains occurred over luteal cells.  At the later wash 
period, most of the grains were associated with blood vessels. 
Finally, we examined the uptake of ~2SI-BSA  by the perfused 
ovary and  compared its distribution  with that of ~25I-HDL 
(rat and human), since albumin may be present as a contam- 
inant  in  some  lipoprotein  preparations.  In  each  of three 
animals, the results were identical. After perfusion for 15 min 
with '25I-BSA followed by a  3-min buffer wash, silver grains 
were  concentrated  over blood  vessels  and  over  cells  that 
resembled macrophages (Fig.  12) but were sparse over luteal 
cells.  This pattern of grain distribution contrasted markedly 
with that of ~25I-human or rat HDL. 
An  examination  of silver  grain  distribution  in  electron 
micrographs confirmed that  luteal  cells,  identified  by their 
characteristic fine structure, were the predominant type of cell 
that accumulated  J25I-hHDL3. In electron microscope auto- 
radiographs, as described above for the light microscope au- 
toradiographic studies, silver grains were more abundant after 
shorter periods of wash (3-30 min) than after longer periods 
(60-120 min). The grain distribution over labeled luteal cells 
was quantified  after  various  periods  of wash  as  described 
above. After shorter periods of wash (e.g., 3-30 rain), 65% of 
236 grains in 48 cells were associated with the plasma mem- 
brane (i.e., on or within 250 nm of this structure), with 35% 
over the interior of the luteal cell. Of the plasma membrane 
grains,  >50%  were localized over processes, i.e.,  thin  cyto- 
plasm-filled extensions of the plasma membrane (Fig.  13 a). 
It appeared that most of the plasma membrane grains were 
associated with  regions  of the  plasmalemma that  lacked  a 
602  THE JOURNAL OF  CELL BIOLOGY . VOLUME 97,  1983 FIGURE  12  Light  micro- 
scope autoradiograph  show- 
ing localization  of 12Sl-bovine 
serum  albumin.  This  field 
from a perfusion-fixed ovary 
contains  several  luteal cells 
and a portion of the connec- 
tive tissue filling the center 
of the corpus  luteum. After 
perfusion  for  15  min  with 
1251-BSA (106 cpm/ml of per- 
fusate; specific  activity, 300 
cpm/ng protein) and a brief 
buffer wash, few silver grains 
were associated with  luteal 
cells (Lu). Instead, they were 
heavily  concentrated  over 
cells that resembled macro- 
phages (arrows). Blood ves- 
sel, by. Compare with Figs.  9 
and 10 c. APP-treated; day 6 
post-hCG  injection;  1-mo 
autoradiographic  exposure; 
x  1,500. 
morphologically  identifiable  bristle  coat  (Fig.  13b).  After 
longer wash periods there appeared to be a shift in silver grain 
distribution.  By  90  min  of wash,  the  percentage of grains 
along the  plasma membrane had declined slightly,  to  51%, 
with a corresponding rise in that over the cytoplasm, to 49% 
(118 grains in 31  cells). A further decrease in the percentage 
of grains over the plasma membrane, to 34%, was observed 
at 120 min of wash; at this time 66% of 167 grains in 30 cells 
were associated with luteal cell cytoplasm (Fig.  13 c). 
DISCUSSION 
Our results indicated that the  in  situ perfused ovary of the 
gonadotropin-primed immature rat  is a  suitable  model for 
the study of lipoprotein metabolism. The ovary remains func- 
tional during the periods of perfusion used, since it remains 
able to secrete steroid  hormones and to respond to trophic 
stimuli and lipoproteins. In APP-treated rats, the addition of 
hHDL3 to the perfusate brought about a stimulation of pro- 
gestin secretion by the ovary, raising it two- to threefold above 
that  for  ovaries  not  receiving  lipoproteins.  This  response 
occurred  even  though  the  levels  of hHDLa  used  supplied 
cholesterol at concentrations only one-third to one-half of the 
normal circulating values for this sterol. It is unlikely that the 
elevated  levels of progestin  were  merely a  consequence  of 
heightened secretion. After perfusion of the ovary with HDL 
reconstituted  with  [3H]cholesteryl  linoleate,  tritium-labeled 
progestin appeared in the effluent, indicating that sterol car- 
ried by HDL was converted to steroid.  Infusion of LH also 
produced a  vigorous secretory response in  non-APP treated 
rats, even when this gonadotropin was delivered to the ovary 
120 min after the perfusion was initiated. 
Our studies further demonstrated that perfused ovaries take 
PAAVOLA AND STRAUSS  Lipoprotein Uptake by Rat Ovaries  603 FIGURE 13  Electron microscope autoradiographs  of rat ovaries perfused with 12Sl-hHDL~.  After 15-min perfusion with 12Sl-hHDL3 
(106 cpm/ml of perfusate) and a brief buffer wash, silver grains occurred primarily along the surfaces of luteal cells, often over 
villus-like processes of the plasma membrane (a, arrowheads). Most of these grains seemed to be associated with segments of 
the plasmalemma  that lacked  a bristle  coat (b,  arrowhead).  After longer wash  periods,  an  increased  number of grains were 
observed over the cytoplasm of luteal cells (c) and fewer grains were observed at the cell surface (arrowhead). All, APP-treated; 
day 7 post-hCG  injection; perfusion-fixation; 5-mo autoradiograpic  exposure, a, ×  19,100; b, x  18,900; c, x  18,800. 
up ~25I-labeled  human HDL3 by a process that is temperature 
dependent and lipoprotein specific.  At 37"C, accumulation of 
~25I-hHDL3 by the ovary reached a maximum after 15 min of 
perfusion  with  label.  Thus,  the  time course  for  uptake  of 
radiolabeled hHDL by the  perfused  ovary was remarkably 
similar to that for both dispersed ovarian cells and ovaries in 
vivo (30,  33).  When  binding  was carried  out  in  the  cold, 
however,  uptake of ~25I-hHDL3 by the  perfused ovary was 
reduced by 80%. The inclusion of excess unlabeled hHDL in 
the perfusate markedly suppressed the accumulation of ~2sI- 
hHDL3, suggesting that the uptake of labeled ligand by the 
perfused ovary involves a finite number of binding sites.  We 
also found that unlabeled hLDL competed less effectively for 
t2~I-hHDL3 uptake than  did  unlabeled  hHDL,  indicating a 
lipoprotein specificity to the uptake process. Taken together, 
these data suggest  that the  accumulation of ~25I-hHDL3 oc- 
curred at the physiologic binding site, presumably the HDL 
receptor. 
Treatment  of gonadotropin-primed  immature  rats  with 
APP reduced plasma cholesterol concentrations from 50 mg/ 
dl to <15  mg/dl. In these animals, uptake of 125I-hHDL3 by 
perfused ovaries was severalfold greater than that for ovaries 
of rats not treated with APP. This finding is presumably due 
to the reduced occupancy of HDL receptors by endogenous 
lipoproteins and,  perhaps,  to  an  increase  in  HDL binding 
sites as a consequence of lowered plasma cholesterol levels. 
604  THE  }OURNAL OF  CELL BIOLOGY , VOLUME 97,  1983 We identified corpora lutea as the ovarian compartment 
which  most actively accumulates  ~25I-hHDL3. These obser- 
vations constitute the first morphological localization of HDL 
accumulation in intact steroid secreting tissue. By using ~zsI- 
human HDL essentially free of apolipoprotein E as our probe, 
we insured that only the binding sites for HDL were visual- 
ized,  and  not  those  for  LDL.  Moreover,  the  lipoprotein- 
specific nature of our autoradiographic localization was veri- 
fied by competition controls in which ovaries were perfused 
simultaneously with  J25I-hHDL3 and an excess of unlabeled 
hHDL or hLDL.  In addition,  both  125I-rat HDL and  ~zsI- 
human HDL labeled autoradiographically the same compart- 
ments in the perfused ovary. Thus, we can assume that the 
use of a heterologous lipoprotein as a probe did not give rise 
to an abnormal pattern of binding among ovarian structures. 
Finally, by perfusing some ovaries with  ~25I-BSA, we ruled 
out  the  possibility  that  albumin,  a  contaminant  of some 
lipoprotein preparations, was localized instead of HDL. 
Besides localizing  ~25I-hHDL3 to corpora lutea,  light and 
electron microscope autoradiography have pinpointed luteal 
cells as the main type of  cell that accumulates this lipoprotein. 
Schuler et al. (30)  suggested,  in an earlier study of dispersed 
cells, that HDL was taken up by ovarian parenchymal cells. 
However, the precise identity of the cells was not established 
in that work. In discussing the possible mechanisms involved 
in the metabolism of HDL by adrenal gland in vivo, Kovanen 
et al. (19)  pointed out that binding sites for HDL need not 
reside on adrenocortical parenchymal cells but could occur 
on other nearby cells, such as capillary endothelial cells. Our 
findings,  however,  appear to  rule  out  this  possibility as  a 
major mechanism by which sterol is delivered to luteal cells. 
On  the  contrary,  they  imply  that  luteal  cells  are  directly 
responsible for obtaining the substrate they use in the synthesis 
of steroids. 
Our light microscopic autoradiographic observations sug- 
gested that  ~25I-hHDL3 accumulates at the surfaces of luteal 
cells. Uptake was especially heavy on those surfaces that faced 
the vascular spaces. However, grains were also observed along 
the  interfaces between  adjacent  luteal  cells,  indicating that 
binding sites for the  lipoprotein  were not  restricted to  the 
perivascular surfaces of luteal cells.  These impressions were 
confirmed by electron  microscope autoradiography,  which 
clearly demonstrated that binding sites for 12~I-hHDL3 were 
associated with the plasma membranes of luteal cells. These 
findings  support  the  suggestion,  largely  from  biochemical 
studies, that the surfaces of steroid-secreting cells bear specific 
binding sites for HDL. For example, Christie et al. (10) have 
reported that uptake of 125I-hHDL is greatest in that fraction 
of rat ovaries containing the highest 5'-nucleotidase activity, 
an enzyme considered to be a marker for plasma membrane. 
Of the silver grains we found associated with luteal cell plasma 
membranes, 50% occurred over processes, slender cytoplasm- 
filled projections of the plasmalemma. Receptors for ~25I-hCG 
are also particularly numerous along villous processes of rat 
luteal cells (13,  22). The majority of the binding sites for ~25I- 
hHDL3, whether on processes or not,  do not appear to be 
concentrated  over coated  pits  or  over linear  bristle-coated 
segments of the plasma membrane. On the other hand, LDL 
receptors  are  associated  with  such  specializations  in  both 
human fibroblasts (4) and rat granulosa cells in vitro (L. G. 
Paavola and J. F.  Strauss, unpublished observations). Thus, 
HDL binding sites of rat luteal cells appear to differ from the 
classical  LDL receptors in several ways, including their bio- 
chemical properties and location along the plasma membrane. 
An  intriguing  observation  in  the  current  study  was  the 
presence of silver grains near the nucleus. On the basis of cell 
size and the resolution of autoradiography with 125I, it seems 
likely that these perinuclear grains arose from a  radioactive 
source within the cell, rather than from ~25I-hHDL3  associated 
with the cell surface. It is therefore tempting to speculate that 
grains in this location reflect possible internalization of all or 
part of the HDL particle. Other data also suggest that at least 
some HDL apolipoprotein may be internalized by luteal cells. 
Schuler et al.  (30),  who  noted  that  after brief exposure of 
dispersed  ovarian  cells  to  proteases  only  part  of the  cell- 
associated  ~25I-HDL was  released,  have  suggested  that  the 
fraction of radioactivity not susceptible to enzymic degrada- 
tion may represent internalized HDL. 
Even though  rat ovaries clearly use HDL as a  source of 
sterol, the mechanisms involved in liberating cholesterol from 
HDL particles remain vague. Several suggestions have been 
made, including  the  facilitation of cholesterol  uptake from 
HDL by plasma membrane lipases (17).  It is also possible 
that,  after interaction with the plasma membrane, HDL is 
internalized and processed in  a  manner similar to that de- 
scribed for LDL (6). Although our observations and those of 
others suggest that internalization of HDL may occur, addi- 
tional  work  is  necessary to clarify the  relationship,  if any, 
between ingestion of HDL and release of sterol to the cell. 
After a  15-min pulse with ~25I-hHDL3  and a 30- (non-APP 
treated rats) or 60- (APP-treated rats) min wash with buffer 
lacking label, the amount of radioactivity associated with the 
ovary declined by ~75%  when compared with that present 
in this organ at shorter periods of wash, and then remained 
more or less constant throughout the rest of the wash. Auto- 
radiographs of this material revealed that there was a striking 
decrease in the number of silver grains associated with luteal 
cells as wash time was increased;  the grains that remained 
were in a perivascular location. The basis for the decrease in 
the level of radioactivity in the ovary, specifically the luteal 
cells, after longer wash periods cannot be established from the 
current data. However, it may reflect, among other things, (a) 
dissociation of intact J25I-hHDL3 from the cell surface to the 
vascular  bed,  (b)  internalization  and  degradation  of  1251- 
hHDL3, or (c) both. The grains localized in perivascular areas 
may represent accumulation of ~25I-hHDL3 or products of its 
degradation by macrophages. 
Steroid-secreting tissues of several species possess LDL re- 
ceptors and utilize LDL as a source of cholesterol for steroid 
hormone synthesis (7,  10, 29). In the case of rats, biochemical 
data indicate that ovarian granulosa cells, when in vitro, can 
use LDL as a sterol source (27). Morphological studies on the 
uptake of gold-labeled hLDL by rat granulosa cells in culture 
suggest that this lipoprotein interacts with the plasma mem- 
brane and is internalized by these cells (L. G. Paavola and J. 
F.  Strauss,  unpublished  observations). However, unlike  the 
situation for a  number of species, including humans, where 
LDL is the main cholesterol-carrying lipoprotein, HDL is the 
principal sterol-transporting lipoprotein in rats (12).  Indeed, 
rodents seem to be somewhat unusual in that their steroido- 
genic tissues can use both LDL and HDL (3, 12). Nevertheless, 
since HDL appears to be the preferred cholesterol carrier in 
vivo for rats, we have dealt specifically with the mechanisms 
of HDL uptake and  have not addressed the  issue  of LDL 
receptors in the in situ perfused ovary. 
In conclusion,  the  data  presented  here provide evidence 
PAAVOLA AND  STRAUSS  Lipoprotein Uptake by Rat Ovaries  605 that ~25I-hHDL3 is taken up by in situ perfused ovaries of rats, 
and  that  this  accumulation  involves a  specific  interaction 
between  the  lipoprotein  and  a  binding site  located  on  the 
plasma  membrane  of luteal  cells.  We  have  alluded  to  the 
possibility that HDL or some portion of it may be internalized 
by  luteal  cells.  Studies  in  progress  are  aimed  at  providing 
further information on how the ovary processes HDL at the 
cellular level. 
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